Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0431 add-on to metformin versus glipizide add-on to metformin in type 2 diabetes
2004-002159-16Phase 3Completed
- Sponsor
- MSD Finland
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by MSD Finland. Started Sep 2004; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-002159-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002159-16.